Goldman Sachs: Now Is The Time To Get In On Teva's Turnaround By: Benzinga via Benzinga December 15, 2017 at 11:01 AM EST Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced Thursday a plan to eliminate more than 25 percent of its worldwide ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR